Skip to content
The Nexus
DossierENTITY

Bioshield

Coverage of Bioshield in the Nexus archive.

Earliest in view: Jun 18 · 10:30 UTCMost recent: Jun 18 · 10:30 UTC
Co-mentioned in this coverage
Patrick Soon-Shiongperson1pancreatic cancertopic1FDAorganization1STAT+organization1
Recent coverage
  • HEALTHJun 18 · 10:30 UTCSTAT NEWS
    STAT+: In pancreatic cancer, Patrick Soon-Shiong makes promises he has not kept

    Patrick Soon-Shiong's claims about transforming pancreatic cancer treatment with novel immunotherapies are criticized for lacking clinical evidence, with a gap between his promises and actual FDA-approved outcomes. The article highlights his history in treating pancreatic cancer and the 'Bioshield' mission, while noting financial self-interest and regulatory scrutiny.